Protective effect of murine sarcoma virus-superinfected mouse tumor cells against outgrowth of corresponding noninfected tumor
- PMID: 705875
- DOI: 10.1097/00007890-197811000-00008
Protective effect of murine sarcoma virus-superinfected mouse tumor cells against outgrowth of corresponding noninfected tumor
Abstract
Cultured lines of three newly established methylcholanthrene-induced tumors, MBK and MBL in CBA and MC57M in C57BL mice, and two mammary tumors, SBfnHC in CBA and S3W in ASW mice, were superinfected in vitro with Moloney sarcoma or leukemia virus (MSV, MLV). After superinfection, they expressed the Moloney virus-determined cell surface antigen (MCSA) and murine C-type viral p30 antigen, and produced NB-tropic C-type virus. The virus-infected tumors became more rejectable in normally susceptible syngeneic mice compared with the original noninfected line. There was no difference in 400-rad irradiated hosts. Mice that have rejected the virus-infected tumors showed an increased resistance to the corresponding noninfected tumor. The protective effect was comparable, with only one exception, to the immunizing effect of irradiated, noninfected cells. In vitro tests showed that small numbers of viable MSV-infected MBL generated cytotoxic spleen cells against both uninfected and MSV-infected MBL in syngeneic mice, while the same numbers of viable noninfected MBL did not induce cytotoxic cells. Relatively large numbers of irradiated MBL and MSV-MBL had a similar activity in inducing cytotoxic spleen cells against MBL in syngeneic hosts.
Similar articles
-
In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.Cancer Res. 1979 Dec;39(12):4887-93. Cancer Res. 1979. PMID: 387218
-
Cell-mediated reactivity to antigens shared by Moloney-virus-induced lymphomas (LSTRA) and certain 3-methylcholanthrene-induced mouse sarcomas.Int J Cancer. 1979 Apr 15;23(4):555-64. doi: 10.1002/ijc.2910230418. Int J Cancer. 1979. PMID: 86527
-
Dissecting the immune response to moloney murine sarcoma/leukemia virus-induced tumors by means of a DNA vaccination approach.J Virol. 1999 Mar;73(3):2280-7. doi: 10.1128/JVI.73.3.2280-2287.1999. J Virol. 1999. PMID: 9971811 Free PMC article.
-
T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.J Immunol. 1982 Feb;128(2):774-9. J Immunol. 1982. PMID: 6459385 No abstract available.
-
Characterization of gP85gag as an antigen recognized by Moloney leukemia virus-specific cytolytic T cell clones that function in vivo.J Exp Med. 1985 Jul 1;162(1):128-44. doi: 10.1084/jem.162.1.128. J Exp Med. 1985. PMID: 3891902 Free PMC article. Review.
Cited by
-
Leukocyte subpopulations elicited by a nontumorigenic variant of B16 melanoma: their role in direct rejection of the melanoma and in prevention of tumorigenesis in Winn assays.J Exp Med. 1982 Dec 1;156(6):1723-38. doi: 10.1084/jem.156.6.1723. J Exp Med. 1982. PMID: 6983560 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous